Pharmacists in Dover, Ohio


13 Pharmacists found in Dover
female pharmacist

Alyssa Nehlen


Pharmacist
515 Union Ave, Dover, OH 44622
330-602-8490    

female pharmacist

Mrs. Cathy Sue Brinkman, RPH


Pharmacist
3000 N Wooster Ave, Dover, OH 44622
330-364-3079     330-343-0264

female pharmacist

Mrs. Ellen K Harnish, RPH


Pharmacist
710 Boulevard St, Dover, OH 44622
330-602-9473     330-343-2442



male pharmacist

Mr. Eric M Durbin, RPH


Pharmacist
3000 N Wooster Ave, Dover, OH 44622
330-364-2301     330-343-0264

female pharmacist

Erin Marie Deeds, RPH


Pharmacist
700 Boulevard St, Dover, OH 44622
330-602-9473    

male pharmacist

Garret Weaver, PHARMD


Pharmacist
300 Oxford St, Dover, OH 44622
330-364-7508    

male pharmacist

Jason Rosnick


Pharmacist
515 Union Ave, Dover, OH 44622
330-602-8490    

male pharmacist

Mr. Jerry S Marlowe, RPH


Pharmacist
207 E 3rd St, Dover, OH 44622
330-343-3199     330-602-0918

female pharmacist

Dr. Jessica S Fisher, PHARM.D.,CGP,CDM,FAS


Pharmacist - Pharmacotherapy
207 E 3rd St, Dover, OH 44622
180-034-3319    

male pharmacist

Mr. Larry Nolan Owen, R.PH.


Pharmacist
3000 N Wooster Ave, Dover, OH 44622
330-343-5157    

male pharmacist

Dr. Nicole E Lewis, PHARM.D.


Pharmacist
204 S Bellevue Ave, Dover, OH 44622
330-365-1085     330-756-1080

male pharmacist

Steven John Gooding, RPH


Pharmacist
3000 N Wooster Ave, Dover, OH 44622
330-364-3079    

male pharmacist

Mr. Willard Walter Johnson Jr., RPH


Pharmacist - Pharmacotherapy
4284 Boy Scout Rd Ne, Dover, OH 44622
330-771-4457    


Type of Pharmacists:
Psychiatric Pharmacist: A licensed pharmacist who has demonstrated specialized knowledge and skill in optimizing care of patients with psychiatric illness by assessing and monitoring patients, recognizing drug-induced problems, and recommending appropriate treatment plans.
Oncology Pharmacist: A licensed pharmacist who has demonstrated specialized knowledge and skill in developing, recommending, implementing, monitoring, and modifying pharmacotherapeutic plans to optimize outcomes in patients with malignant diseases.